RegenPRP™ is a medical treatment that uses platelet-rich plasma from the patient's own blood to enhance and tissue regeneration.
Cellular Selectivity & Concentration Flexibility Models for individualized approaches toward Regenerative Medicine.
RegenLab® technology involves the use of a patent protected process, using a thixotropic gel to separate blood components.
RegenKit® BCT prepares platelet-rich plasma efficiently, offering a simple solution for natural healing treatments.
RegenKit® Wound Gel is designed to enhance tissue regeneration by using platelet-rich plasma for wound care and healing.
RegenKit® THT® provides consistent preparation of platelet-rich plasma, ensuring high-quality results for regenerative therapies.
Regen® ATS enables the preparation of autologous thrombin serum to support natural tissue repair and regeneration.
Enhanced HA combines hyaluronic acid with PRP to deliver optimal results for skin and joint rejuvenation.
Supplemental devices include centrifuges and applicators, etc.
RegenLab® USA manufactures and distributes medical devices exclusively within the United States. All products comply with FDA regulations, ensuring safety and efficacy for the U.S. market.
Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.
Intellectual Property Rights (IPRs) as Core assets, patents and trademarks of RegenLab USA LLC and/or Regen Lab SA.
Explore RegenLab USA LLC and Regen Lab SA’s comprehensive Knowledge Base, your go-to resource for in-depth information on our core assets
Stay informed with the latest updates, announcements, and events from RegenLab® USA.
Explore insights, industry trends, and expert articles on regenerative medicine and innovative technologies.
Discover BioBridge, a global platform advancing innovation in regenerative medicine and biotechnology.
Have questions? Reach out to RegenLab® USA for support, inquiries, or collaboration opportunities.
